Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Marc Ferrante, Geert D’Haens, Vipul Jairath, Silvio Danese, Minhu Chen, Subrata Ghosh, Tadakazu Hisamatsu, Jarosław Kierkuś, Britta Siegmund, Sonja M. Bragg, Wallace Crandall, Frédérick Durand, Emily Hon, Zhantao Lin, Michelle Ugolini Lopes, Nathan Morris, Marijana Protić, Hilde Carlier, Bruce E Sands, Emiliano Tron, Fernanda Dorado, Lena Thin, Rupert W. Leong, Hansjoerg Seltenreich, Britt Christensen, Anthony Croft, Simon Ghaly, Robert Koch, Walter Reinisch, Sonja Heeren, Peter Bossuyt, Marc Ferrante, Fabio Luiz Maximiano, Lígia Yukie Sassaki, Carolina Baía, D. Poli, A D S Carlos, Carlos Fernando de Magalhães Francesconi, Alexander De Sa Rolim, J. Razera, Joaquim Simões Neto, Rodrigo Rocco, Jonathas Stifft, Jonathan Soldera, Jonathas Stifft, C. Clemente, Sandra Di Felice Boratto, Luciana Teixeira de Campos, Marcelo Rodrigues Borba, Gregory Rosenfeld, Terry Ponich, Allen Lim, Chadwick Williams, Bruce Musgrave, Chadwick Williams, Wenjia Liu, Chengdang Wang, Hong Guo, Chunxiao Chen, Yan Chen, Qian Cao, Jie Zhong, Min Xu, Yufang Wang, Changqing Zheng, Xiang Gao, Youxiang Chen, Yinglei Miao, Lin Wang, Deliang Liu, Bangmao Wang, Zhengji Song, Xiaowei Liu, Baili Chen, Wen Jiang, Qiang Zhan, Kaiguang Zhang, Hong Shen, Zhaotao Li, Xiaoyan Wang, Zhaotao Li, Dean Tian, Leilei Chen, Wen Tang, Vladimir Borzan, Željko Krznarić, Miroslava Volfová, Jiri Pumprla, Lucie Veberova, Michal Tichý, Jan Gregar, David Stepek, Jan Ulbrych, Pavel Drastich, Zdenek Papik, Jan Matouš, Martin Lukáš, Radka Koskova, Jan Fallingborg, Romain Altwegg